Celanese Corporation (CE) recently announced the launch of Glaukos Corporation's iDose TR. This uses CE's VitalDose EVA to offer continuous medication release for the treatment of glaucoma.The majority of glaucoma and ocular hypertension patients do not adhere to topical drug regimens due to complex dosing courses, adverse effects and eye-drop sensitivity. Sustained delivery of medications is a significant technique for addressing noncompliance and enhancing treatment results. With iDose TR and VitalDose EV ...

DALLAS--(BUSINESS WIRE)--Celanese Corporation (NYSE: CE), a global specialty materials and chemical company, announced the launch of iDose® TR by Glaukos Corporation using Celanese’s VitalDose® EVA to provide sustained drug release for the treatment of glaucoma. The majority of glaucoma and ocular hypertension patients are non-compliant with topical medication use due to complex dosing regiments, side effects, and eye-drop intolerance. Sustained delivery of therapeutics provides an important approach in ...

DALLAS--(BUSINESS WIRE)--Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today announced that Timothy Go has been elected to the company’s Board of Directors. Mr. Go, 57, is President, Chief Executive Officer, and a member of the Board of Directors of HF Sinclair Corporation. He will begin his Board service effective immediately, bringing the total number of Board members to twelve (eleven of which are independent). HF Sinclair Corporation is a leading independent energy ...

While companies who rank among the earnings losers category don’t obviously generate confidence, it’s also important to keep in mind the big picture. Technology juggernaut Nvidia (NASDAQ:NVDA) provides an extreme example of this.In the third quarter of 2023, Nvidia posted earnings per share of 58 cents. This tally represented a stinker against the estimated EPS target of 70 cents. The company took it personally. Since then, the company has been beating its targets, continuing to impress onlookers up until t ...

We have a structured approach to reviewing talent with management, as well as with the Board of Directors. This includes discussions of employee development, executive succession, diversity, talent pipelines and workforce planning requirements. We regularly report to the Board of Directors on talent management strategies across functional areas, and annually review executive succession with the Board of Directors. Available Information — Securities and Exchange Commission ("SEC") Filings and Corporate Gover ...

Financial Data and Key Metrics - The company expects a significant uplift in M&M earnings in Q1 2024, with Q1 anticipated to be the highest quarterly EBITDA since the acquisition [13] - Synergies for 2024 are expected to be $150 million, with 40% showing up in M&M and the majority in the EM profile [17] - The company achieved $100 million in synergies in 2023, slightly lower than earlier expectations due to volume-related issues [75] - The foundational level of earnings in acetyls is $1.3 billion, with an expected increase of $100 million in 2024 due to productivity from the Clear Lake expansion [85] Business Line Data and Key Metrics - The M&M business is expected to see recovery in auto versus seasonal destocking experienced in Q4 2023, with initial fixed cost improvements becoming more meaningful in the second half of 2024 [38] - The nylon business is seeing stability and expanding margins, with efforts to recover lost volume share [70] - The acetate tow business exceeded its $245 million EBIT target in 2023, contributing to the stabilization of the acetyl chain [77] Market Data and Key Metrics - In China, demand for consumption is approaching normal levels, but exports to Europe remain depressed [30] - In the Americas, demand is gradually returning, with improvement in industrial sectors but seasonal destocking in auto [30] - Europe is expected to take longer to return to normal demand patterns, with some improvement in construction and VAM pricing [32] Company Strategy and Industry Competition - The company is focused on controlling controllable factors, with a $11 to $12 guide assuming diminishing destocking but not a significant uptick in demand [31] - The SAP integration was completed smoothly, with the last version going live on February 1, 2024, marking a significant step in achieving synergies [16][40] - The company is committed to deleveraging to a 3x target, with a focus on free cash flow generation and maintaining investment grade [91][95] Management Commentary on Operating Environment and Future Outlook - Management is confident in delivering $150 million in synergies for 2024, driven by footprint optimization, SAP integration, and cross-sell opportunities [72] - The company expects a meaningful lift in M&M earnings in Q1 2024, driven by lower raw material and fixed costs [13] - The outlook for 2024 assumes below-normal demand patterns but without destocking, with a focus on controllable factors [31] Other Important Information - The company completed its SAP integration, which is expected to help achieve the next level of synergy and improve operational efficiency [40] - The Clear Lake acetic acid expansion is expected to contribute $100 million in productivity, with potential for higher returns in periods of high demand [55] - The company is focused on creating a business model for nylon that delivers a minimum of 25% EBITDA in any economic environment [102] Q&A Session Summary Question: What are the expectations for the M&M business in 2024? - The company expects recovery in auto and initial fixed cost improvements, with more meaningful impacts in the second half of 2024 [38] Question: How is the SAP integration progressing? - The SAP integration was completed smoothly, with the last version going live on February 1, 2024, and is expected to help achieve synergies [16][40] Question: What is the outlook for raw material costs in 2024? - The company is focused on controlling controllable factors, with lower raw material costs expected to flow through earnings [41] Question: What are the expectations for auto builds in 2024? - The company expects auto builds to be flattish, with its business growing 150 to 200 basis points above industry builds [80] Question: What is the impact of the Red Sea disruptions on the company? - The company has not seen significant impacts from the Red Sea disruptions, with its global supply chain providing flexibility [110] Question: What is the long-run EBITDA potential for the Clear Lake acetic acid expansion? - The Clear Lake expansion is expected to contribute $100 million in productivity, with potential for higher returns in periods of high demand [55]

Celanese Corporation (CE) reported fourth-quarter 2023 earnings from continuing operations of $6.43 per share, down 8.5% from $7.03 reported in the prior-year quarter.Adjusted earnings in the fourth quarter were $2.24 per share, up from $1.44 reported in the prior year. It lagged the Zacks Consensus Estimate of $2.29.Revenues of $2,569 million increased roughly 9.4% year over year but missed the Zacks Consensus Estimate of $2,610.6 million.Segment HighlightsNet sales in the Engineered Materials unit were $1 ...

Celanese (CE) reported $2.57 billion in revenue for the quarter ended December 2023, representing a year-over-year increase of 9.4%. EPS of $2.24 for the same period compares to $1.44 a year ago.The reported revenue represents a surprise of -1.59% over the Zacks Consensus Estimate of $2.61 billion. With the consensus EPS estimate being $2.29, the EPS surprise was -2.18%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street exp ...

Celanese (CE) came out with quarterly earnings of $2.24 per share, missing the Zacks Consensus Estimate of $2.29 per share. This compares to earnings of $1.44 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -2.18%. A quarter ago, it was expected that this chemical company would post earnings of $2.20 per share when it actually produced earnings of $2.50, delivering a surprise of 13.64%.Over the last four quarters, the company ...

Analysts on Wall Street project that Celanese (CE) will announce quarterly earnings of $2.29 per share in its forthcoming report, representing an increase of 59% year over year. Revenues are projected to reach $2.61 billion, increasing 11.2% from the same quarter last year.Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Before a company reveals its earnin ...